ZA921659B - Low dose dry pharmaceutical preparations - Google Patents

Low dose dry pharmaceutical preparations

Info

Publication number
ZA921659B
ZA921659B ZA921659A ZA921659A ZA921659B ZA 921659 B ZA921659 B ZA 921659B ZA 921659 A ZA921659 A ZA 921659A ZA 921659 A ZA921659 A ZA 921659A ZA 921659 B ZA921659 B ZA 921659B
Authority
ZA
South Africa
Prior art keywords
disclosed
weight
agent
pharmaceutical preparations
tablet
Prior art date
Application number
ZA921659A
Other languages
English (en)
Inventor
Pieter De Haan
De Haan Pieter
Marcus Johannes Deurloo
Johannes Deurloo Marcus
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8207548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA921659(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA921659B publication Critical patent/ZA921659B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA921659A 1991-03-12 1992-03-05 Low dose dry pharmaceutical preparations ZA921659B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200524 1991-03-12

Publications (1)

Publication Number Publication Date
ZA921659B true ZA921659B (en) 1992-11-25

Family

ID=8207548

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921659A ZA921659B (en) 1991-03-12 1992-03-05 Low dose dry pharmaceutical preparations

Country Status (17)

Country Link
US (1) US5382434A (de)
EP (1) EP0503521B2 (de)
JP (1) JP3474210B2 (de)
KR (1) KR100198017B1 (de)
CN (1) CN1039086C (de)
AT (1) ATE125155T1 (de)
AU (1) AU651869B2 (de)
CA (1) CA2062428C (de)
DE (1) DE69203488T3 (de)
DK (1) DK0503521T4 (de)
ES (1) ES2077897T5 (de)
FI (1) FI100770B (de)
GR (1) GR3017737T3 (de)
IE (1) IE67345B1 (de)
NO (1) NO305055B1 (de)
NZ (1) NZ241915A (de)
ZA (1) ZA921659B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924617B (en) 1991-03-25 1994-05-27 Boart International S A Pty Lt A percussion drill bit
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
US5928668A (en) * 1993-12-21 1999-07-27 Applied Analytical Industries, Inc. Method for dry blend compression of medicaments
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
DK0782449T3 (da) * 1994-09-22 2003-08-04 Akzo Nobel Nv Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
EP0820237A4 (de) * 1995-01-25 1999-01-20 Wrigley W M Jun Co Verbesserte einstaubmischung und verfahren zur herstellung von kaugummi mit ihrer hilfe
NZ312113A (en) * 1995-06-22 1998-06-26 Akzo Nobel Nv Compressed dry-granulation of desogestrel
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
DE19917347A1 (de) * 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
ITMI991582A1 (it) * 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
JP2003518038A (ja) * 1999-12-20 2003-06-03 ニコラス， ジェイ カークホフ， 流動床噴霧乾燥によるナノ粒子製造方法
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
DE60130657T2 (de) * 2000-07-20 2008-07-03 Campina Nederland Holding B.V. Methode zur herstellung eines kristallinen tablettierungshilfstoffes, der so erhaltene hilfsstoff und seine verwendung
DK1361881T3 (da) * 2000-12-14 2006-02-20 Ortho Mcneil Pharm Inc Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
CN1494419A (zh) * 2001-03-06 2004-05-05 协和发酵工业株式会社 口腔内快速崩解制剂
CA2440365A1 (en) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Use of a spray-dried powder comprising a sugar alcohol
IL158390A0 (en) 2001-05-01 2004-05-12 Pfizer Prod Inc Method for manufacturing a low dose pharmaceutical composition
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US6962908B2 (en) 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
US7833545B2 (en) 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2178540A4 (de) * 2007-08-01 2012-01-04 Stellan Hjerten Pharmazeutische zusammensetzung zur adsorption auf der zelloberfläche von pathogenen mikroben
WO2010042930A1 (en) * 2008-10-10 2010-04-15 Ahmed Salah U Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
MX2011009053A (es) 2009-03-09 2012-04-02 Spi Pharma Inc Excipientes de compresion directa con alta capacidad de compactacion y durables y sistemas de excipiente.
HUP0900698A2 (en) 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
EP2354150A1 (de) * 2010-02-09 2011-08-10 Laboratoire Theramex Verfahren zur Herstellung von Gestoden
WO2012120365A1 (en) 2011-03-07 2012-09-13 Aurobindo Pharma Limited Stable pharmaceutical composition comprising ethinyl estradiol
CN102416003A (zh) * 2011-12-08 2012-04-18 南京优科生物医药有限公司 一种制备恩替卡韦片剂的方法
AU2014226192B2 (en) * 2013-03-04 2018-07-26 Besins Healthcare Luxembourg Sarl Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US3802914A (en) * 1972-04-10 1974-04-09 Kraftco Corp Method of treating lactose
SE378109B (de) * 1972-05-19 1975-08-18 Bofors Ab
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2524902C2 (de) * 1975-06-02 1984-10-25 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
US4143136A (en) * 1976-11-20 1979-03-06 Akzona Incorporated Method of contraception
DE2716323C2 (de) * 1977-04-07 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide

Also Published As

Publication number Publication date
DE69203488T2 (de) 1996-01-11
ATE125155T1 (de) 1995-08-15
HK1002018A1 (en) 1998-07-24
FI921023A0 (fi) 1992-03-09
US5382434A (en) 1995-01-17
ES2077897T5 (es) 2006-06-16
JPH0578251A (ja) 1993-03-30
EP0503521A1 (de) 1992-09-16
EP0503521B2 (de) 2005-11-09
CA2062428A1 (en) 1992-09-13
NO920958D0 (no) 1992-03-11
GR3017737T3 (en) 1996-01-31
CN1064810A (zh) 1992-09-30
DE69203488D1 (de) 1995-08-24
NZ241915A (en) 1994-04-27
FI921023L (fi) 1992-09-13
KR100198017B1 (ko) 1999-06-15
NO920958L (no) 1992-09-14
DK0503521T3 (da) 1995-11-27
CA2062428C (en) 2002-07-30
NO305055B1 (no) 1999-03-29
AU1211992A (en) 1992-09-17
EP0503521B1 (de) 1995-07-19
JP3474210B2 (ja) 2003-12-08
ES2077897T3 (es) 1995-12-01
IE67345B1 (en) 1996-03-20
CN1039086C (zh) 1998-07-15
FI100770B (fi) 1998-02-27
AU651869B2 (en) 1994-08-04
DE69203488T3 (de) 2006-07-06
KR920017656A (ko) 1992-10-21
IE920634A1 (en) 1992-09-23
DK0503521T4 (da) 2005-12-05

Similar Documents

Publication Publication Date Title
GR3017737T3 (en) Low dose dry pharmaceutical preparations.
KR100384264B1 (ko) 습식과립화에의한 투여단위의제조방법
IL114596A (en) Pharmaceutical compositions containing an active substance blended with a carrier process for preparation thereof and their use for preparation of inhalated drugs
AU3394689A (en) Pharmaceutical compositions
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
EP0391374A3 (de) Verfahren zur Herstellung von Bromocriptin enthaltenden Arzneimittelzubereitungen mit hoher Stabilität und in Beziehung zueinander stehende Produkte
NO922807L (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
DK0456720T3 (da) Granuleringer med højt ibuprofenindhold
GB1427881A (en) Mixtures containing nitroglycerin and polyvinyl-pyrrolidone
ZA939565B (en) Method for preparing low dose pharmaceutical products.
US4206214A (en) Antithrombotic pharmaceutical compositions containing dipyridamole and sulfinpyrazone
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
EP0414688B1 (de) Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
CA2201040A1 (en) Solid pharmaceutical preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
Fateeva Pharmacokinetics of amphoglucamine in an experiment
WO2001010415B1 (en) A binder for pharmaceutical compositions
NO176948C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i enhetsdoseform omfattende finmalt colestipol-hydroklorid
GB1255805A (en) Improvements in delayed release pharmaceutical preparations and stabilisation of vitamins
EP0347531A3 (de) Verwendung von 1,3-Dithiol-2-Thion-Derivate bei der Behandlung von Lebererkrankungen
JPS5462327A (en) Remedy for dna virus infectious disease
EP0367509A3 (de) Formulierungen